Abstract
We support M. A. Hamburg's Plea for increased funding of regulatory science (“Advancing regulatory science,” Editorial, 25 February, p. [987][1]). We also share her ambition to modernize the regulatory system and bring 21st-century science and technology to drug development and drug evaluations
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
